Opiate addicts and chronic pain sufferers were sent into a panic in August when the DEA announced its intention to place kratom’s two main constituent chemicals on schedule 1—making sale and possession of the plant illegal. Now, a preliminary document, set to be posted to the Federal Register tomorrow, reverses that decision.
The Washington Post reports the new document, which reads, “Since publishing that notice, DEA has received numerous comments from members of the public challenging the scheduling action.” This reaction from the agency suggests that write-in campaigns from Speciosa, American Kratom, and others were effective in keeping kratom from becoming one of the most controlled substances in the country. Similar calls to action appeared on the homepages of a variety of online kratom vendors, urging customers to contact DEA as well as their local congressmen. Currently, the DEA is accepting comments from the public until December 1.